Form 8-K - Current report:
SEC Accession No. 0001193125-24-056922
Filing Date
2024-03-04
Accepted
2024-03-04 08:06:24
Documents
57
Period of Report
2024-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d759933d8k.htm   iXBRL 8-K 28572
2 EX-99.1 d759933dex991.htm EX-99.1 52623
7 GRAPHIC g759933ex99_1p10g1.jpg GRAPHIC 210283
8 GRAPHIC g759933ex99_1p11g1.jpg GRAPHIC 342516
9 GRAPHIC g759933ex99_1p12g1.jpg GRAPHIC 358910
10 GRAPHIC g759933ex99_1p13g1.jpg GRAPHIC 241563
11 GRAPHIC g759933ex99_1p14g1.jpg GRAPHIC 300214
12 GRAPHIC g759933ex99_1p15g1.jpg GRAPHIC 325481
13 GRAPHIC g759933ex99_1p16g1.jpg GRAPHIC 308602
14 GRAPHIC g759933ex99_1p17g1.jpg GRAPHIC 360093
15 GRAPHIC g759933ex99_1p18g1.jpg GRAPHIC 291272
16 GRAPHIC g759933ex99_1p19g1.jpg GRAPHIC 257474
17 GRAPHIC g759933ex99_1p1g1.jpg GRAPHIC 384922
18 GRAPHIC g759933ex99_1p20g1.jpg GRAPHIC 313168
19 GRAPHIC g759933ex99_1p21g1.jpg GRAPHIC 221943
20 GRAPHIC g759933ex99_1p22g1.jpg GRAPHIC 283320
21 GRAPHIC g759933ex99_1p23g1.jpg GRAPHIC 222808
22 GRAPHIC g759933ex99_1p24g1.jpg GRAPHIC 385010
23 GRAPHIC g759933ex99_1p25g1.jpg GRAPHIC 280188
24 GRAPHIC g759933ex99_1p26g1.jpg GRAPHIC 386465
25 GRAPHIC g759933ex99_1p27g1.jpg GRAPHIC 258168
26 GRAPHIC g759933ex99_1p28g1.jpg GRAPHIC 362991
27 GRAPHIC g759933ex99_1p29g1.jpg GRAPHIC 265120
28 GRAPHIC g759933ex99_1p2g1.jpg GRAPHIC 802680
29 GRAPHIC g759933ex99_1p30g1.jpg GRAPHIC 457904
30 GRAPHIC g759933ex99_1p31g1.jpg GRAPHIC 380509
31 GRAPHIC g759933ex99_1p32g1.jpg GRAPHIC 348631
32 GRAPHIC g759933ex99_1p33g1.jpg GRAPHIC 354493
33 GRAPHIC g759933ex99_1p34g1.jpg GRAPHIC 255384
34 GRAPHIC g759933ex99_1p35g1.jpg GRAPHIC 381873
35 GRAPHIC g759933ex99_1p36g1.jpg GRAPHIC 257647
36 GRAPHIC g759933ex99_1p37g1.jpg GRAPHIC 255925
37 GRAPHIC g759933ex99_1p38g1.jpg GRAPHIC 276659
38 GRAPHIC g759933ex99_1p39g1.jpg GRAPHIC 345892
39 GRAPHIC g759933ex99_1p3g1.jpg GRAPHIC 489797
40 GRAPHIC g759933ex99_1p40g1.jpg GRAPHIC 401340
41 GRAPHIC g759933ex99_1p41g1.jpg GRAPHIC 445500
42 GRAPHIC g759933ex99_1p4g1.jpg GRAPHIC 339670
43 GRAPHIC g759933ex99_1p5g1.jpg GRAPHIC 329606
44 GRAPHIC g759933ex99_1p6g1.jpg GRAPHIC 351974
45 GRAPHIC g759933ex99_1p7g1.jpg GRAPHIC 355530
46 GRAPHIC g759933ex99_1p8g1.jpg GRAPHIC 363868
47 GRAPHIC g759933ex99_1p9g1.jpg GRAPHIC 278319
  Complete submission text file 0001193125-24-056922.txt   19323413

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nams-20240304.xsd EX-101.SCH 4098
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240304_def.xml EX-101.DEF 13741
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240304_lab.xml EX-101.LAB 22929
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240304_pre.xml EX-101.PRE 14709
59 EXTRACTED XBRL INSTANCE DOCUMENT d759933d8k_htm.xml XML 6048
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 24712902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)